Literature DB >> 10599887

Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese.

M Matsushita1, N Tsuchiya, T Nakayama, J Ohashi, T Shibue, M Shiota, T Oka, A Yamane, K Tokunaga.   

Abstract

Tumor necrosis factor alpha plays a substantial role in a number of conditions such as inflammation, autoimmunity, insulin resistance and sleep. Three new single nucleotide polymorphisms, -1,031 T/C, -863 C/A and -857 T/C, were recently identified in the upstream 5'-flanking region of TNFA in the Japanese population. In the present study, we developed polymerase chain reaction (PCR)-preferential homoduplex formation assay for the single-step allele typing of TNFA, and determined the genotypes of 271 healthy unrelated Japanese individuals. Four haplotypes, -1,031/-863/-857 TCC, TCT, CAC and CCC, were found to constitute the majority, if not all, of the TNFA alleles of healthy Japanese population. These alleles were designated as TNFA-U01, -U02 -U03 and -U04, respectively, in the order of frequency. Based on HLA-A, -B and -DRB1 genotypes together with TNFA genotypes, multi-locus haplotypes were analyzed. Significant positive associations were observed between TNFA-U01 and A*3303, B*5201, B*4403, B*4601, B*0702, DRB1*1502, DRB1*0101, DRB1*1302, between TNFA-U02 and B*5401, B*3501, DRB1*0405, DRB1*0407, between TNFA-U03 and B*4006, B*4002, DRB1*0803, DRB1*0802, DRB1*0403, DRB1*0901, and between TNFA-U04 and B*4801. Four-locus haplotype estimation revealed that A*3303-B*4403-TNFA-U01-DRB1*1302, A*2402-B*5201-TNFA-U01-DRB1*1502 and A*2402-B*5401-TNFA-U02-DRB1*0405 constitute major extended haplotypes in Japanese. Interestingly, TNFA alleles previously shown to have a higher promoter activity (U02, U03) were found to form haplotypes with certain DRB1 alleles associated with T helper 1 (Th1)-dominant diseases such as rheumatoid arthritis, insulin dependent diabetes mellitus and Crohn's disease in Japanese. In contrast, TNFA allele with a low promoter activity (U01) is in linkage disequilibrium with the DRB1 alleles associated with T helper 2 (Th2)-dominant diseases such as atopic dermatitis and ulcerative colitis. These observations raise the possibility that TNFA upstream promoter region polymorphisms contribute to some of the HLA-disease associations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599887     DOI: 10.1034/j.1399-0039.1999.540505.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis.

Authors:  Masao Ota; Yoshihiko Katsuyama; Hideaki Hamano; Takeji Umemura; Akinori Kimura; Kaname Yoshizawa; Kendo Kiyosawa; Hirofumi Fukushima; Seiamak Bahram; Hidetoshi Inoko; Shigeyuki Kawa
Journal:  Immunogenetics       Date:  2006-11-21       Impact factor: 2.846

Review 2.  The role of the immune system in the insulin resistance syndrome.

Authors:  Michael R Lewis; Russell P Tracy
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

3.  Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease.

Authors:  Yung-Che Chen; Shih-Feng Liu; Chien-Hung Chin; Chao-Chien Wu; Chung-Jen Chen; Hsueh-Wen Chang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Meng-Chih Lin
Journal:  Lung       Date:  2010-03-30       Impact factor: 2.584

4.  Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis.

Authors:  Koichi Okamoto; Satoshi Makino; Yoko Yoshikawa; Asumi Takaki; Yumie Nagatsuka; Masao Ota; Gen Tamiya; Akinori Kimura; Seiamak Bahram; Hidetoshi Inoko
Journal:  Am J Hum Genet       Date:  2002-12-31       Impact factor: 11.025

5.  Is the association between TNF-alpha-308 A allele and DMT1 independent of HLA-DRB1, DQB1 alleles?

Authors:  Grazyna Deja; Przemysława Jarosz-Chobot; Joanna Polańska; Urszula Siekiera; Ewa Małecka-Tendera
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.